Variant report

Variant	nsv1003934
Chromosome Location	chr3:21960795-21999895
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr3:21996134-21996664	IMR90	lung:	n/a	n/a
2	CEBPB	chr3:21996174-21996533	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr3:21983754-21984218	IMR90	lung:	n/a	chr3:21984197-21984210
4	CEBPB	chr3:21961852-21962386	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr3:21961843-21962449	IMR90	lung:	n/a	n/a
6	CHD2	chr3:21962058-21962212	Hela-S3	cervix:	n/a	n/a
7	CTCF	chr3:21998853-21998886	GM13976	blood:	n/a	n/a
8	CTCF	chr3:21996780-21996930	GM06990	blood:	n/a	n/a
9	CTCF	chr3:21988251-21988325	LNCaP	prostate:	n/a	n/a
10	CTCF	chr3:21980128-21980180	MCF-7	breast:	n/a	n/a
11	E2F4	chr3:21995949-21996485	MCF10A-Er-Src	breast:	n/a	n/a
12	E2F4	chr3:21983881-21984127	MCF10A-Er-Src	breast:	n/a	n/a
13	EBF1	chr3:21985565-21986097	GM12878	blood:	n/a	n/a
14	EP300	chr3:21983614-21984173	SK-N-SH	brain:	n/a	chr3:21983882-21983889 chr3:21983861-21983870
15	EP300	chr3:21996206-21996540	Hela-S3	cervix:	n/a	n/a
16	EP300	chr3:21983774-21984300	SK-N-SH_RA	brain:	n/a	chr3:21983882-21983889 chr3:21983861-21983870
17	EP300	chr3:21961863-21962287	Hela-S3	cervix:	n/a	chr3:21962128-21962142 chr3:21962123-21962137 chr3:21962115-21962129 chr3:21962116-21962130
18	EP300	chr3:21983838-21984230	SK-N-SH_RA	brain:	n/a	chr3:21983882-21983889 chr3:21983861-21983870
19	EP300	chr3:21983617-21984398	SK-N-SH	brain:	n/a	chr3:21983882-21983889 chr3:21983861-21983870
20	ESR1	chr3:21978643-21978921	ECC-1	luminal epithelium:	n/a	n/a
21	ESR1	chr3:21979690-21979940	ECC-1	luminal epithelium:	n/a	chr3:21979806-21979823
22	FOS	chr3:21983687-21984101	MCF10A-Er-Src	breast:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983863-21983870
23	FOS	chr3:21996970-21997170	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr3:21983679-21984147	MCF10A-Er-Src	breast:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983863-21983870
25	FOS	chr3:21996984-21997174	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr3:21983686-21984346	MCF10A-Er-Src	breast:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983863-21983870
27	FOS	chr3:21996172-21996566	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr3:21996203-21996529	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr3:21983706-21984092	MCF10A-Er-Src	breast:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983863-21983870
30	FOS	chr3:21996160-21996599	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr3:21961826-21962233	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr3:21995955-21996602	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr3:21961860-21962227	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr3:21961844-21962221	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr3:21961821-21962247	MCF10A-Er-Src	breast:	n/a	n/a
36	FOSL2	chr3:21983666-21984256	SK-N-SH	brain:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983863-21983870
37	FOSL2	chr3:21961845-21962303	SK-N-SH	brain:	n/a	chr3:21962255-21962264
38	GATA3	chr3:21964667-21965023	SK-N-SH	brain:	n/a	n/a
39	GATA3	chr3:21961777-21962447	SK-N-SH	brain:	n/a	chr3:21962145-21962155
40	GATA3	chr3:21961784-21962327	SK-N-SH	brain:	n/a	chr3:21962145-21962155
41	GATA3	chr3:21983576-21984442	SK-N-SH	brain:	n/a	n/a
42	GATA3	chr3:21983637-21984346	SK-N-SH	brain:	n/a	n/a
43	GATA3	chr3:21964673-21965053	SK-N-SH	brain:	n/a	n/a
44	JUN	chr3:21961894-21962246	Hela-S3	cervix:	n/a	n/a
45	JUN	chr3:21977486-21977516	H1-hESC	embryonic stem cell:	n/a	n/a
46	JUND	chr3:21961818-21962405	SK-N-SH	brain:	n/a	chr3:21962255-21962264
47	JUND	chr3:21961867-21962285	SK-N-SH	brain:	n/a	chr3:21962255-21962264
48	JUND	chr3:21983745-21984022	HepG2	liver:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983860-21983871 chr3:21983863-21983870
49	JUND	chr3:21983694-21984337	SK-N-SH	brain:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983860-21983871 chr3:21983863-21983870
50	JUND	chr3:21983737-21984331	SK-N-SH	brain:	n/a	chr3:21983861-21983871 chr3:21983860-21983872 chr3:21983861-21983870 chr3:21983862-21983871 chr3:21983861-21983871 chr3:21983860-21983871 chr3:21983863-21983870

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:21960904-21960954	BE2_C	brain:	n/a
2	chr3:21960904-21960954	AG09309	skin:	n/a
3	chr3:21960904-21960954	BJ	skin:	n/a
4	chr3:21960904-21960954	HCF	heart:	n/a
5	chr3:21960904-21960954	NB4	blood:	n/a
6	chr3:21960904-21960954	GM12878	blood:	n/a
7	chr3:21960904-21960954	Caco-2	colon:	n/a
8	chr3:21960904-21960954	SKMC	muscle:	n/a
9	chr3:21960904-21960954	PFSK-1	brain:	n/a
10	chr3:21960904-21960954	HPAEpiC	pulmonary alveolar:	n/a
11	chr3:21960904-21960954	HRE	kidney:	n/a
12	chr3:21960904-21960954	HMEC	breast:	n/a
13	chr3:21960904-21960954	PrEC	prostate:	n/a
14	chr3:21960904-21960954	SK-N-SH_RA	brain:	n/a
15	chr3:21960904-21960954	AG10803	skin:	n/a
16	chr3:21960904-21960954	HEEpiC	esophagus:	n/a
17	chr3:21960904-21960954	NHBE	bronchial:	n/a
18	chr3:21960904-21960954	HIPEpiC	eye:	n/a
19	chr3:21960904-21960954	U87	brain:	n/a
20	chr3:21960904-21960954	HCT-116	colon:	n/a
21	chr3:21960904-21960954	ovcar-3	ovarian:	n/a
22	chr3:21960904-21960954	HRCEpiC	kidney:	n/a
23	chr3:21960904-21960954	ProgFib	skin:	n/a
24	chr3:21960904-21960954	Hela-S3	cervix:	n/a
25	chr3:21960904-21960954	AG09319	gingival:	n/a
26	chr3:21960904-21960954	T-47D	breast:	n/a
27	chr3:21960904-21960954	Hepatocyte	liver:	n/a
28	chr3:21960904-21960954	HCM	heart:	n/a
29	chr3:21960904-21960954	AG04450	lung:	fetal
30	chr3:21960904-21960954	ECC-1	luminal epithelium:	n/a
31	chr3:21960904-21960954	AG04449	skin:	fetal
32	chr3:21960904-21960954	SK-N-MC	brain:	n/a
33	chr3:21960904-21960954	HepG2	liver:	n/a
34	chr3:21960904-21960954	HAEpiC	amniotic membrane:	n/a
35	chr3:21960904-21960954	HCPEpiC	choroid plexus:	n/a
36	chr3:21960904-21960954	MCF-7	breast:	n/a
37	chr3:21960904-21960954	GM19239	blood:	n/a
38	chr3:21960904-21960954	CMK	blood:	n/a
39	chr3:21960904-21960954	SAEC	small airway:	n/a
40	chr3:21960904-21960954	GM06990	blood:	n/a
41	chr3:21960904-21960954	HRPEpiC	eye:	n/a
42	chr3:21960904-21960954	AoSMC	blood vessel:	n/a
43	chr3:21960904-21960954	H1-hESC	embryonic stem cell:	embryo
44	chr3:21960904-21960954	HL-60	blood:	n/a
45	chr3:21960904-21960954	NH-A	brain:	n/a
46	chr3:21960904-21960954	IMR90	lung:	fetal
47	chr3:21960904-21960954	A549	lung:	n/a
48	chr3:21960904-21960954	HUVEC	blood vessel:	n/a
49	chr3:21960904-21960954	LNCaP	prostate:	n/a
50	chr3:21960904-21960954	SK-N-SH	brain:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UBE2E2-2	chr3:21984058-21984156	ENSG00000223351
2	lnc-UBE2E2-2	chr3:21998628-21998684	ENSG00000223351
3	lnc-UBE2E2-7	chr3:21982020-21982219	l_2330_chr3:21975326-21982219_testes
4	lnc-UBE2E2-7	chr3:21975327-21975419	l_2330_chr3:21975326-21982219_testes
5	lnc-UBE2E2-2	chr3:21998631-21998684	ENSG00000223351

Variant related genes	Relation type
ZNF385D-AS2	TF binding region
ZNF385D-AS2	CpG island

Extended variants
information (count: 2261 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:2261 , 50 per page) page: 1 2 3 4 5 6 7 ... 46

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4094000	chr3:21960795-21960796	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs558543022	chr3:21960823-21960824	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs28399781	chr3:21960827-21960828	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs571776262	chr3:21960832-21960833	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs192081751	chr3:21960853-21960854	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs259509	chr3:21960873-21960874	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs1479989	chr3:21960877-21960878	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs372745193	chr3:21960891-21960892	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs1479988	chr3:21960927-21960928	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs567011166	chr3:21960950-21960951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs370125229	chr3:21960964-21960965	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs534036290	chr3:21960974-21960975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs544084892	chr3:21960986-21960987	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs555824984	chr3:21961012-21961013	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs573990375	chr3:21961035-21961036	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs185163159	chr3:21961038-21961039	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs563788427	chr3:21961041-21961042	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs557320457	chr3:21961054-21961055	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs575632644	chr3:21961061-21961062	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs1479987	chr3:21961062-21961063	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs564136797	chr3:21961138-21961139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs528244451	chr3:21961140-21961141	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs1479986	chr3:21961151-21961152	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs1619770	chr3:21961158-21961159	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs568900341	chr3:21961197-21961198	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs528894177	chr3:21961201-21961202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs377610642	chr3:21961229-21961230	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs185091002	chr3:21961245-21961246	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs554835383	chr3:21961258-21961259	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs1684524	chr3:21961267-21961268	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs552002172	chr3:21961335-21961336	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs150641907	chr3:21961351-21961352	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs534393928	chr3:21961363-21961364	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs189417354	chr3:21961369-21961370	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs548747319	chr3:21961373-21961374	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs35063591	chr3:21961413-21961414	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs1684525	chr3:21961421-21961422	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs538313959	chr3:21961431-21961432	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs192724671	chr3:21961432-21961433	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs578041827	chr3:21961457-21961458	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs1564411	chr3:21961463-21961464	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs4370048	chr3:21961514-21961515	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs538938197	chr3:21961535-21961536	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs540409335	chr3:21961560-21961561	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs368782832	chr3:21961568-21961569	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs184116846	chr3:21961578-21961579	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs543860364	chr3:21961591-21961592	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs259510	chr3:21961593-21961594	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs532760402	chr3:21961613-21961614	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs551826223	chr3:21961629-21961630	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
lymphocytic leukemia	21291569	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Esophageal cancer	20955586	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Squamous cell cancer	20885788	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Melanoma	20688739	CNVD

Chromatin state (count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:21954400-21960800	Weak transcription	Placenta Amnion	Placenta Amnion
2	chr3:21955600-21960800	Weak transcription	NHLF	lung
3	chr3:21955800-21961200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr3:21956400-21960800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr3:21956400-21960800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr3:21957400-21960800	Weak transcription	HUES64 Cell Line	embryonic stem cell
7	chr3:21957400-21960800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr3:21957400-21961000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
9	chr3:21960400-21961000	Enhancers	Pancreatic Islets	Pancreatic Islet
10	chr3:21960400-21961800	Enhancers	Fetal Lung	lung
11	chr3:21960400-21962400	Enhancers	Muscle Satellite Cultured Cells	--
12	chr3:21960400-21963000	Enhancers	NHDF-Ad	bronchial
13	chr3:21960600-21961200	Enhancers	Brain Germinal Matrix	brain
14	chr3:21960600-21961400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr3:21960600-21961800	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr3:21960600-21961800	Enhancers	Fetal Stomach	stomach
17	chr3:21960600-21962000	Enhancers	ES-I3 Cell Line	embryonic stem cell
18	chr3:21960600-21962400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr3:21960600-21962400	Enhancers	NH-A	brain
20	chr3:21960800-21961000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
21	chr3:21960800-21961200	Enhancers	H1 Cell Line	embryonic stem cell
22	chr3:21960800-21961200	Enhancers	H9 Cell Line	embryonic stem cell
23	chr3:21960800-21961200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr3:21960800-21961600	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr3:21960800-21961800	Enhancers	iPS-20b Cell Line	embryonic stem cell
26	chr3:21960800-21962000	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr3:21960800-21962200	Enhancers	HUES64 Cell Line	embryonic stem cell
28	chr3:21960800-21962200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
29	chr3:21960800-21962400	Enhancers	Fetal Heart	heart
30	chr3:21960800-21962400	Enhancers	Placenta Amnion	Placenta Amnion
31	chr3:21960800-21963000	Enhancers	NHLF	lung
32	chr3:21961000-21962200	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr3:21961200-21961400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr3:21961200-21962400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr3:21961400-21961800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr3:21961400-21961800	Enhancers	Osteobl	bone
37	chr3:21961400-21962000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr3:21961600-21961800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr3:21963000-21971800	Weak transcription	NHDF-Ad	bronchial
40	chr3:21971400-21971800	Enhancers	Fetal Heart	heart
41	chr3:21971800-21972400	Enhancers	NHDF-Ad	bronchial
42	chr3:21971800-21983800	Weak transcription	Fetal Heart	heart
43	chr3:21975600-21976800	Enhancers	Pancreatic Islets	Pancreatic Islet
44	chr3:21975800-21976400	Enhancers	Brain Germinal Matrix	brain
45	chr3:21976000-21976400	Enhancers	Fetal Lung	lung
46	chr3:21976400-21981800	Weak transcription	Fetal Lung	lung
47	chr3:21979800-21980200	Enhancers	Skeletal Muscle Female	skeletal muscle
48	chr3:21979800-21980200	Enhancers	HSMM	muscle
49	chr3:21980600-21982600	Enhancers	Fetal Stomach	stomach
50	chr3:21981800-21982000	Enhancers	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links